跨部门协同治理计划,用于控制中国的抗菌素耐药性,采用"一个健康"方法:混合方法研究研究的研究协议
Zhixin Fan1,2,3, Jia Yin1,2,3, Zhibin Zhang4
1Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
BMJ open
|July 30, 2025
概括
本研究通过制定跨部门协同作用的战略,解决了中国农村地区抗菌素耐药性 (AMR) 治理问题. 它旨在通过县级的实用,可持续的治理措施来改善抗菌耐药性控制.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 传染病控制和控制传染病
背景情况:
- 抗菌素耐药性 (AMR) 是一个重大的全球健康威胁,中国农村地区在治理方面面临着特别的挑战.
- 目前,中国农村地区的抗菌药物治理是分散的,缺乏有效地将政策转化为实际的,可持续的措施.
- 跨部门的合作对于在这些地区有效制抗菌素耐药性至关重要.
研究的目的:
- 调查和了解中国农村县对AMR跨部门协同治理的现状.
- 开发和应用一个评估工具来评估AMR协同治理能力.
- 确定和提出最佳的协同治理策略,以打击AMR.
主要方法:
- 第一阶段:政策文件和半结构面试的内容分析,以探索治理机制.
- 第二阶段:开发一种AMR协同治理能力评估工具,使用修改后的Delphi调查和案例分析.
- 第三阶段:人工智能的应用,包括大型语言模型和深层多层模型,用于策略模拟和预测.
主要成果:
- 该研究旨在获得关于治理能力的经验数据,并确定有效的战略.
- (结果正在等待) 开发的评估工具将提供对抗药物耐药性治理有效性的定量衡量.
- (结果正在等待) 由人工智能驱动的模型将预测不同治理策略的结果.
结论:
- 这项研究预计将提供基于证据的建议,以加强中国农村地区的抗药性治理.
- 这些发现将有助于更有效,更可持续,更实用的方法来控制抗菌素耐药性.
- 该研究旨在弥合政策目标和AMR控制措施的实地实施之间的差距.
相关概念视频
International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
Primary Healthcare Services
1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Development of Antibiotic Resistance
207
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
207
Antimicrobial Effectiveness
163
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
163
Drug Control Governance: Regulatory Bodies and Their Impact
250
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
250


